Health Invest Partners Ab Bristol Myers Squibb CO Transaction History

Health Invest Partners Ab

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$48.48 - $57.85 $1.12 Million - $1.33 Million	23,000 Added 35.38%	88,000 $4.52 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $2.26 Million - $2.68 Million	-33,000 Reduced 33.67%	65,000 $4.68 Million
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $7,020 - $4.15 Million	54,000 Added 122.73%	98,000 $6.97 Million
Q2 2022 Jul 08, 2022	SELL	$72.62 - $79.98 $2.76 Million - $3.04 Million	-38,000 Reduced 46.34%	44,000 $3.39 Million
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $1.11 Million - $1.33 Million	-18,000 Reduced 18.0%	82,000 $5.99 Million
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $3.86 Million - $4.5 Million	72,000 Added 257.14%	100,000 $6.24 Million
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $7.04 Million - $8.25 Million	-119,000 Reduced 80.95%	28,000 $1.66 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $2.91 Million - $3.17 Million	47,000 Added 47.0%	147,000 $9.82 Million
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $2.73 Million - $3.07 Million	-46,000 Reduced 31.51%	100,000 $6.31 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $5.92 Million - $6.71 Million	102,600 Added 236.41%	146,000 $9.06 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $2.6 Million - $2.84 Million	43,400	43,400 $2.66 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

Stay updated on Health Invest Partners Ab with notifications on news.